Correction to: Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type

Affiliations

¹ Departments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA.
² Departments of Psychology and of Computer Science, University of Southern California, Los Angeles, CA, USA.
³ Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
⁴ Departments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA. scarmich@g.ucla.edu.

Published Erratum

Shirin Z Birjandi et al. Transl Stroke Res. 2021 Aug.

. 2021 Aug;12(4):691.

doi: 10.1007/s12975-020-00858-1.

¹ Departments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA.
² Departments of Psychology and of Computer Science, University of Southern California, Los Angeles, CA, USA.
³ Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
⁴ Departments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA. scarmich@g.ucla.edu.

No abstract available

Erratum for

Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type.
Birjandi SZ, Abduljawad N, Nair S, Dehghani M, Suzuki K, Kimura H, Carmichael ST. Birjandi SZ, et al. Transl Stroke Res. 2021 Apr;12(2):303-315. doi: 10.1007/s12975-020-00819-8. Epub 2020 May 6. Transl Stroke Res. 2021. PMID: 32378029 Free PMC article.